Damien T.

At Medartis, we develop, manufacture and distribute titanium screws and plates, surgical instruments and system solutions for fracture fixation. Headquartered in Basel, Switzerland, our company is represented worldwide through 12 subsidiaries and a wide distributor network. We place the highest priority on maintaining stringent quality standards, continuous development and innovation, including comprehensive service provision for physicians, operating-room (OR) staff and patients. Our long-term customer relations based on partnerships have formed the foundation for our sustainable success since the company’s founding. Dr. h.c. Thomas Straumann founded Medartis in 1997 and returned to the field of osteosynthesis in cranio-maxillofacial surgery. Our product portfolio was expanded in 2004 with the APTUS Hand and Distal Radius systems. This paved the way for a successful entry into orthopedics. All Medartis products are developed in close consultation with hand and traumatology specialists as well as experienced OR teams. Our goal is to continually improve early functional rehabilitation through our high-quality products and exclusively developed technologies.

We are pleased to inform you that Boston Scientific has completed its acquisition of Symetis in May 2017. For further information on the ACURATE neo Valve System and jobs at Symetis please visit the Boston Scientific website.

We are pleased to inform you that Boston Scientific has completed its acquisition of Symetis in May 2017. For further information on the ACURATE neo Valve System and jobs at Symetis please visit the Boston Scientific website.

CeQur®, a medical device company dedicated to simplifying mealtime insulin delivery for individuals on multiple daily injections, manufactures CeQur Simplicity, a simple-to-use wearable insulin delivery device enabling discreet, convenient and injection-free bolus dosing. In June 2024, the company announced the FDAs recent 510(k) clearance of CeQur Simplicity for an extended wear duration from 3 to 4 days. One CeQur Simplicity 4-day wearable patch holds up to 200 units of rapid-acting insulin administered in two-unit increments and replaces, on average, twelve daily mealtime injections over four days. CeQur is headquartered in Horw, Switzerland. Please visit myceqursimplicity.com for more information.

Cirpack is a leading software company that provides "Full IP"​ scalable and multi-service IP Unified Communications and Core Network solutions for the use of corporates, telecommunications operators and service providers. Cirpack solutions help telecom operators to address both "Home"​ and "Enterprise"​ markets. Cirpack product lines are based on highly innovative technological solutions designed for Unified Communications (Voice, Video, Data, WebRTC, Softphone, Fixed Mobile Convergence ...) and Core Network (Softswitch and IMS, SBC, SIP Trunking, Centralized routing ...) and associated professional services. Cirpack technologies are marketed both in Licence and SaaS mode and benefit of a 24/7 support. Cirpack has offices in France, Germany, Mexico, Lebanon and Vietnam. Cirpack operates via a VAR network. More than sixty million business and residential customers daily enjoy the benefits of Cirpack solutions and services through strong relationships with over 120 customers acting on three continents. Renowned for robustness, scalability and reliability of its solutions, Cirpack is the ideal partner, offering agility and responsiveness in order to support its customers in their development strategies.

Hôpital de La Tour is a private, independent, human-sized facility offering high-level acute care. Committed to delivering the best quality of life to its patients, La Tour places continuous improvement and medical excellence at the heart of its priorities. The hospital’s ambitions are backed by highly skilled doctors and nursing staff, as well as state-of-the-art infrastructure. In fact, La Tour is the only private institution in French-speaking Switzerland to offer 24/7 emergency care, internal medicine, intensive and continuous care, as well as pneumology services for acute care. It is also equipped with an intermediate neonatal care unit and a sports-medicine facility as part of the Swiss Olympic Medical Center. Officially sanctioned by the Canton of Geneva, La Tour is able, in some specific cases, to welcome patients without supplemental insurance. Likewise, ambulatory consultations are accessible to anyone with basic Swiss health coverage (LAMal). La Tour’s annual figures include: 7,000 inpatients ● 300,000 outpatients including 40,000 emergencies ● 6,000 surgeries ● 50 doctors trained in 11 medical disciplines ● 1,000 employees ● 500 active licensed doctors. For more information: www.latour.ch

At Medartis, we develop, manufacture and distribute titanium screws and plates, surgical instruments and system solutions for fracture fixation. Headquartered in Basel, Switzerland, our company is represented worldwide through 12 subsidiaries and a wide distributor network. We place the highest priority on maintaining stringent quality standards, continuous development and innovation, including comprehensive service provision for physicians, operating-room (OR) staff and patients. Our long-term customer relations based on partnerships have formed the foundation for our sustainable success since the company’s founding. Dr. h.c. Thomas Straumann founded Medartis in 1997 and returned to the field of osteosynthesis in cranio-maxillofacial surgery. Our product portfolio was expanded in 2004 with the APTUS Hand and Distal Radius systems. This paved the way for a successful entry into orthopedics. All Medartis products are developed in close consultation with hand and traumatology specialists as well as experienced OR teams. Our goal is to continually improve early functional rehabilitation through our high-quality products and exclusively developed technologies.

We are pleased to inform you that Boston Scientific has completed its acquisition of Symetis in May 2017. For further information on the ACURATE neo Valve System and jobs at Symetis please visit the Boston Scientific website.

We are pleased to inform you that Boston Scientific has completed its acquisition of Symetis in May 2017. For further information on the ACURATE neo Valve System and jobs at Symetis please visit the Boston Scientific website.